Horizon Kinetics Asset Management’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-227
| Closed | -$2.4K | – | 330 |
|
|
2023
Q4 | $2.4K | Hold |
227
| – | – | ﹤0.01% | 320 |
|
|
2023
Q3 | $4.48K | Hold |
227
| – | – | ﹤0.01% | 323 |
|
|
2023
Q2 | $17.3K | Hold |
227
| – | – | ﹤0.01% | 325 |
|
|
2023
Q1 | $21.4K | Hold |
227
| – | – | ﹤0.01% | 324 |
|
|
2022
Q4 | $22.1K | Hold |
227
| – | – | ﹤0.01% | 311 |
|
|
2022
Q3 | $58K | Hold |
227
| – | – | ﹤0.01% | 319 |
|
|
2022
Q2 | $42K | Hold |
227
| – | – | ﹤0.01% | 324 |
|
|
2022
Q1 | $22K | Hold |
227
| – | – | ﹤0.01% | 339 |
|
|
2021
Q4 | $37K | Hold |
227
| – | – | ﹤0.01% | 346 |
|
|
2021
Q3 | $62K | Hold |
227
| – | – | ﹤0.01% | 332 |
|
|
2021
Q2 | $90K | Hold |
227
| – | – | ﹤0.01% | 336 |
|
|
2021
Q1 | $122K | Buy |
+227
| New | +$122K | ﹤0.01% | 330 |
|